Search Results - "Boekholdt, SM"

Standardizing the cardiac radioablation targeting workflow: enabling semi-automated angulation and segmentation of the heart according to the American Heart Association segmented model by Van Der Ree, MH, Visser, J, Planken, RN, Dieleman, EMT, Boekholdt, SM, Balgobind, BV, Postema, PG

“…Abstract Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Dutch Heart Foundation Purpose…”
Get full text

Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies by Sarwar, Nadeem, Sandhu, Manjinder S, Ricketts, Sally L, Butterworth, Adam S, Di Angelantonio, Emanuele, Boekholdt, S Matthijs, Ouwehand, Willem, Watkins, Hugh, Samani, Nilesh J, Saleheen, Danish, Lawlor, Debbie, Reilly, Muredach P, Hingorani, Aroon D, Talmud, Philippa J, Danesh, John

“…Summary Background Whether triglyceride-mediated pathways are causally relevant to coronary heart disease is uncertain. We studied a genetic variant that…”
Get full text

Post corona infection cardiac abnormalities and the risk for sudden cardiac death by Van Hattum, J, Spies, JL, Verwijs, SM, Verwoert, GC, Boekholdt, SM, Groenink, M, Pinto, YM, Wilde, AAM, Jorstad, HT

“…Abstract Funding Acknowledgements Type of funding sources: Other. Main funding source(s): Dutch Olympic Committee*Dutch Sports Federation (NOC*NSF) Amsterdam…”
Get full text

Late gadolinium enhancement of the hinge point is a common finding in asymptomatic ELITE athletes by Verwijs, SM, Van Hattum, JC, Spies, JL, Boekholdt, SM, Planken, RN, Groenink, M, Van Randen, A, Van Luijk, RD, Van Den Berg-Faaij, AM, Bakermans, AJ, Nederveen, AJ, Moen, MH, Pinto, YM, Wilde, AAM, Jorstad, HT

“…Abstract Funding Acknowledgements Type of funding sources: None. Background Late gadolinium enhancement (LGE) demonstrates regional differences in myocardial…”
Get full text

SARS-CoV-2 associated cardiac abnormalities in elite athletes: results from the prospective, longitudinal COMMIT cohort by Van Hattum, J, Verwijs, SM, Davelaar, SE, Daems, JJN, Boekholdt, SM, Groenink, M, Planken, RN, Van Luijk-Snoeks, RD, Van Den Berg-Faay, AM, Moen, MH, Wijne, CACM, Nederveen, AJ, Pinto, YM, Wilde, AAM, Jorstad, HT

“…Abstract Funding Acknowledgements Type of funding sources: Other. Main funding source(s): Dutch National Olympic Committee & National Sports Federation…”
Get full text

Aortic dilatation using cardiac magnetic resonance in asymptomatic ELITE athletes by Verwijs, SM, Van Hattum, JC, Stomilovic, N, Daems, JJN, Boekholdt, SM, Planken, RN, Groenink, M, Van Randen, A, Bakermans, AJ, Nederveen, AJ, Moen, MH, Pinto, YM, Wilde, AAM, Jorstad, HT

“…Abstract Funding Acknowledgements Type of funding sources: None. Purpose Aortic dilatation is associated with acute aortic pathology. Cardiac magnetic…”
Get full text

The sports cardiology team: personalising athlete care through a comprehensive, multidisciplinary approach by Van Hattum, J, Verwijs, SM, De Vries, ST, Boekholdt, SM, Groenink, M, Van Randen, A, Panhuyzen-Goedkoop, NM, Willems, AR, Knobbe, I, Blom, NA, Van Der Crabben, SN, Bijsterveld, NR, Pinto, YM, Wilde, AAM, Jorstad, HT

“…Abstract Funding Acknowledgements Type of funding sources: Other. Main funding source(s): Dutch National Olympic Committee & National Sports Federation…”
Get full text

Normalization of global longitudinal strain after 20 squats in elite athletes by Bruin De- Bon, H, Verwijs, SM, Hattum Van, JC, Blomjous, AGA, Planken, RN, Boekholdt, SM, Groenink, M, Hoogenband Van Den, CR, Moen, MH, Wilde, AAM, Pinto, YM, Bouma, BJ, Jorstad, HT

“…Abstract Funding Acknowledgements Type of funding sources: None. Background/Introduction: Transthoracic echocardiography (TTE) is often the first diagnostic…”
Get full text

1668Body fat distribution as risk factor of new-onset atrial fibrillation in The European Prospective Investigation Into Cancer and Nutrition in Norfolk Study by Neefs, J., Boekholdt, SM, Khaw, KT, Luben, R., Pfister, R., Wareham, NJ, De Groot, JR

Get full text

Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: Individual patient meta-analysis of 13 677 subjects by BOEKHOLDT, S. M, SACKS, F. M, HUMPHRIES, S. E, MILLER, G. J, EIRIKSDOTTIR, G, GUDNASON, V, KAUMA, H, KAKKO, S, SAVOLAINEN, M. J, ARCA, M, MONTALI, A, LIU, S, JUKEMA, J. W, LANZ, H. J, ZWINDERMAN, A. H, KUIVENHOVEN, J. A, KASTELEIN, J. J. P, SHEPHERD, J, FREEMAN, D. J, MCMAHON, A. D, CAMBIEN, F, NICAUD, V, DE GROOTH, G. J, TALMUD, P. J

“…Several studies have reported that the cholesteryl ester transfer protein (CETP) TaqIB gene polymorphism is associated with HDL cholesterol (HDL-C) levels and…”
Get full text

Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease by Boekholdt, S Matthijs, Thompson, John F

“…Since the identification of cholesteryl ester transfer protein (CETP), its role in the modulation of HDL levels and cardiovascular disease has been debated…”
Get full text

Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers by Bijsterveld, Nick R, Moons, Arno H, Boekholdt, S Matthijs, van Aken, Benien E, Fennema, Hein, Peters, Ron J G, Meijers, Joost C M, Büller, Harry R, Levi, Marcel

“…The novel anticoagulant fondaparinux proved to be effective and safe in the postoperative prevention of venous thrombosis. Current phase III trials with this…”
Get full text

Genetic variation at the phospholipid transfer protein locus affects its activity and high-density lipoprotein size and is a novel marker of cardiovascular disease susceptibility by Vergeer, Menno, Boekholdt, S Matthijs, Sandhu, Manjinder S, Ricketts, Sally L, Wareham, Nicholas J, Brown, Morris J, de Faire, Ulf, Leander, Karin, Gigante, Bruna, Kavousi, Maryam, Hofman, Albert, Uitterlinden, Andre G, van Duijn, Cornelia M, Witteman, Jacqueline C M, Jukema, J Wouter, Schadt, Eric E, van der Schoot, Ellen, Kastelein, John J P, Khaw, Kay-Tee, Dullaart, Robin P F, van Tol, Arie, Trip, Mieke D, Dallinga-Thie, Geesje M

“…In contrast to clear associations between variants in genes participating in low-density lipoprotein metabolism and cardiovascular disease risk, such…”
Get full text

Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk population study by Boekholdt, S Matthijs, Kuivenhoven, Jan-Albert, Wareham, Nicholas J, Peters, Ron J G, Jukema, J Wouter, Luben, Robert, Bingham, Sheila A, Day, Nicholas E, Kastelein, John J P, Khaw, Kay-Tee

“…Low plasma levels of cholesteryl ester transfer protein (CETP) are associated with elevated levels of HDL cholesterol (HDL-C), but it remains unclear whether…”
Get full text

IL-8 Plasma Concentrations and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women: The EPIC-Norfolk Prospective Population Study by Boekholdt, S Matthijs, Peters, Ron J.G, Hack, C Erik, Day, Nicholas E, Luben, Robert, Bingham, Sheila A, Wareham, Nicholas J, Reitsma, Pieter H, Khaw, Kay-Tee

“…OBJECTIVE—To study the role of IL-8 in predicting future coronary artery disease (CAD) in apparently healthy men and women. METHODS AND RESULTS—A nested…”
Get full text

Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events by BOEKHOLDT, S. Matthijs, AGEMA, Willem R. P, PETERS, Ron J. G, ZWINDERMAN, Aeilko H, VAN DER WALL, Ernst E, REITSMA, Pieter H, KASTELEIN, John J. P, JUKEMA, J. Wouter

“…Atherosclerosis is increasingly considered to be a chronic inflammatory process. We examined whether genetic variants of the toll-like receptor 4 (TLR4), which…”
Get full text

PLA2G10 Gene Variants, sPLA2 Activity, and Coronary Heart Disease Risk by Guardiola, Montse, Exeter, Holly J, Perret, Claire, Folkersen, Lasse, van’t Hooft, Ferdinand, Eriksson, Per, Franco-Cereceda, Anders, Paulsson-Berne, Gabrielle, Palmen, Jutta, Li, KaWah, Cooper, Jackie A, Khaw, Kay-Tee, Mallat, Ziad, Ninio, Ewa, Karabina, Sonia-Athina, Humphries, Steve E, Boekholdt, S Matthijs, Holmes, Michael V, Talmud, Philippa J

“…BACKGROUND—Observational studies report that secretory phospholipase A2 (sPLA2) activity is a marker for coronary heart disease (CHD) risk, and activity…”
Get full text

Inherited disorders of HDL metabolism and atherosclerosis by Hovingh, G Kees, de Groot, Eric, van der Steeg, Wim, Boekholdt, S Matthijs, Hutten, Barbara A, Kuivenhoven, Jan Albert, Kastelein, John J P

“…Genetic disorders of HDL metabolism are rare and, as a result, the assessment of atherosclerosis risk in individuals suffering from these disorders has been…”
Get full text

Serum Levels of Type II Secretory Phospholipase A2 and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women: The EPIC-Norfolk Prospective Population Study by Boekholdt, S Matthijs, Keller, Tymen T, Wareham, Nicholas J, Luben, Robert, Bingham, Sheila A, Day, Nicholas E, Sandhu, Manjinder S, Jukema, J Wouter, Kastelein, John J.P, Hack, C Erik, Khaw, Kay-Tee

“…OBJECTIVES—To study the prospective relationship between serum levels of type II secretory phospholipase A2 (sPLA2) and the risk of future coronary artery…”
Get full text

Cholesteryl Ester Transfer Protein (CETP) Inhibition Beyond Raising High-Density Lipoprotein Cholesterol Levels: Pathways by Which Modulation of CETP Activity May Alter Atherogenesis by Klerkx, Anke H.E.M, Harchaoui, Karim El, van der Steeg, Wim A, Boekholdt, S Matthijs, Stroes, Erik S.G, Kastelein, John J.P, Kuivenhoven, Jan Albert

“…Raising high-density lipoprotein cholesterol (HDL-C) is a promising strategy in the struggle to prevent cardiovascular disease, and cholesteryl ester transfer…”
Get full text